DCF — MAT-SU REGIONAL MED CTR
Enterprise Value: $192.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$192.3M
Enterprise Value
$49.0M
PV of Cash Flows
$143.4M
PV of Terminal Value
$230.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $310.8M | $26.4M | 8.0% | $8.6M | $7.8M |
| Year 2 | $320.1M | $30.4M | 9.0% | $11.3M | $9.3M |
| Year 3 | $329.7M | $34.6M | 10.0% | $14.1M | $10.6M |
| Year 4 | $339.6M | $37.4M | 11.0% | $15.8M | $10.8M |
| Year 5 | $349.8M | $39.4M | 11.0% | $16.9M | $10.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $192.3M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$301.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999867442924
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5